|
|
Article: EnteroMedics enters into exclusive obesity device research and development agreement with Mayo Clinic.(EnteroMedics Inc., Mayo Foundation for Medical Education and Research)
- Article from:
- BIOTECH Patent News
- Article date:
- March 1, 2005
CopyrightCOPYRIGHT 2005 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
EnteroMedics, Inc. (St. Paul, MN), a leading developer of medical devices for the treatment of obesity and gastrointestinal disorders, announced that the Mayo Foundation for Medical Education and Research (Rochester, MN) has entered into an exclusive collaborative obesity device research and development agreement with the company. Through this agreement, EnteroMedics will collaborate with a group of physicians and researchers at Mayo Clinic in the field of obesity. Under the terms of this five-year agreement, EnteroMedics and this group of Mayo specialists will collectively work toward the development of new and innovative medical devices for the treatment of obesity. The ...
Related newspaper, magazine, and journal articles:
|
|
Article: EnteroMedics Closes $16.9 Million Series B Financing; ...
PR Newswire;
November 30, 2004 ;
700+ words
... ... Minn., Nov. 30 /PRNewswire/ -- EnteroMedics Inc., a leading developer of medical ... of Charter Life Sciences will join EnteroMedics' board of directors. Current directors ... Knudson, Ph.D., president and CEO of EnteroMedics, will remain on the board. "EnteroMedics ...
|
|